Overview
Timo Ylikomi practices practicing medicine in Tampere, Finland.
His clinical expertise encompasses Methimazole Antenatal Exposure and Necrosis.
He is actively involved in clinical research, co-authoring 24 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Timo Ylikomi
Is Timo Ylikomi a top-rated expert for Methimazole Antenatal Exposure?
MediFind is an objective health platform that identifies experts based on real-world data. Timo Ylikomi is classified as an Experienced expert for Methimazole Antenatal Exposure, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Timo Ylikomi participate in research or clinical trials?
Yes. Timo Ylikomi has published 24 articles and abstracts on conditions like Methimazole Antenatal Exposure. You can view a list of Timo Ylikomi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Methimazole Antenatal ExposureMr. Ylikomi isExperienced. Learn about Methimazole Antenatal Exposure.
- NecrosisMr. Ylikomi isExperienced. Learn about Necrosis.